The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group.
D000328:Adult; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000627:therapeutic use; D003327:Coronary Disease / Q000401:mortality / Q000517:prevention & control*; D003918:Dextrothyroxine / Q000008:administration & dosage / Q000009:adverse effects*; D004562:Electrocardiography; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000517:prevention & control; D009539:Nicotinic Acids / Q000627:therapeutic use; D010919:Placebos; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D004966:Estrogens, Conjugated (USP); D009539:Nicotinic Acids; D010919:Placebos; D014280:Triglycerides; D003918:Dextrothyroxine; D002784:Cholesterol; D002994:Clofibrate